Medical abortion - clinical aspects Gynmed Clinic Vienna, Austria Karolinska University Hospital...
-
Upload
rosalyn-hutchinson -
Category
Documents
-
view
217 -
download
0
Transcript of Medical abortion - clinical aspects Gynmed Clinic Vienna, Austria Karolinska University Hospital...
Medical abortion - clinical aspects
Gynmed Clinic
Vienna, Austria
www.gynmed.atKarolinska University Hospital
Department of Women and Child Health
Stockholm/Sweden
Christian Fiala, MD, PhD
International Association of Abortion and Contraception Associates
www.fiapac.org
Conférence sur l’avortement par médicament-
16 Septembre 2014 - FQPN
www.mifegyne.infowww.misoprostol.org
Museum of Contraception and Abortion
Vienna, www.muvs.org
Medical abortion - clinical aspects, C. Fiala
2
Abortion is the most frequently
performed surgical procedure
in Obstetrics and Gynaecology,
regardless of whether it is illegal or legal.
The quality of care has therefore
a huge impact on the whole society.
Medical abortion - clinical aspects, C. Fiala
3
• 1988: France (49 days LMP)
• 1991: UK (63)
• 1992: Sweden (63)
• 1999 January: Austria (49)
• 2000: most other European countries (49)
• 2000: US, Mifeprex® (49)
• 2007: Portugal; all countries up to 63 days
• 2010: Italy
• Now available in 44 countries
Marketing of mifepristone
Medical abortion - clinical aspects, C. Fiala
4
Medical abortion - clinical aspects, C. Fiala
5
Mifepristone/Mifegyne® /Mifeprex®
www.mifegyne.info
Medical abortion - clinical aspects, C. Fiala
6
Mifepristone
• Steroid competitively blocking hormone receptors
• Affinity to progesterone receptor is 8 times higher than
progesterone
• Affinity to the cortisol receptor is 3 times higher than cortisol
• Fast oral absorption, peak after 1.5 hours
• Half life more than 18 hours
• 3 metabolites, providing 23-33% of the antiprogestagenic
effect in a 600mg dose
Medical abortion - clinical aspects, C. Fiala
7
Mifepristone cont.
• Very safe (no death from the drug reported)
• Side effects minimal (nausea)
• Regimen 200-600 mg (1-3 tablets) followed by a
prostaglandin 36-48 hours later
• The interval is important for the effectiveness
• Rather expensive drug: 22€ (United States 85$) per tablet
Medical abortion - clinical aspects, C. Fiala
8
Inhibits the regression of the corpus luteum
Gestational sac Progesterone Keeps the endometrium
and the gestational sac attached to the uterine wall
Relaxes the uterine muscle
Keeps the cervix closed
Mode of action of progesterone in the uterus
ß-hCG
Medical abortion - clinical aspects, C. Fiala
9
Leads to the regression of the corpus luteum
Gestational sac
Blocks the receptors of progesterone
The endometrium and the gestational sac separates from the uterine wall
The uterine muscle becomes more sensitive to prostaglandin and contracts
The cervix opens
Mode of action of mifepristone
Decreases ß-hCG
Blocks progesterone receptors and thereby induces the clinical symptoms identical and indistinguishable to a miscarriage (corpus luteum insufficiency)
Medical abortion - clinical aspects, C. Fiala
10
Bygdeman & Swahn 1985
Mifepristone, prostaglandins and uterine contractility
The interval is important for the effectiveness
Medical abortion - clinical aspects, C. Fiala
11
www.who.int/reproductive-health/publications/safe_abortion/safe_abortion.html
Medical abortion - clinical aspects, C. Fiala
12
• Voluntary medical abortion <63 days in
combination with a prostaglandin
(misoprostol/gemeprost)
• Priming of the cervix prior to surgical abortion
• Medical abortion for medical indications in the 2. +
3. Trimester
• Induction of labour in intrauterine foetal death
Mifepristone: approved indications in Europe
Medical abortion - clinical aspects, C. Fiala
13
Website: - information (www.gynmed.org)
First contact /telephone: - Is pregnancy confirmed?- Has the patient been able to talk to someone close?- Has the decision for the abortion been taken?- Answer questions or refer to the website- Exclude contra indications- Make appointment
Day 1: - Ultrasound, hCG (gynaecological examination) - Blood group- Counselling: abortion only if the decision is clear otherwise give an appointment one week later- 1 or 3 tab mifepristone
Day 3: - <49 days LMP = 2 tab misoprostol (Cytotec®) orally 50-63 days LMP = 4 tab misoprostol vaginaly- Option for up to 3 hours in the institution (rarely used)- Make sure patient has sufficient analgesics- Start oral contraception the next day
Day 8 -14: - ultrasound and/or hCG
The procedure up to 63 days LMP
Medical abortion - clinical aspects, C. Fiala
14
When does the abortion take place?
Phase of psychological confrontation -Phase of coming to a decision
Mifepristone
Prostaglandin
• Detachment of the gestational sac
• Bleeding may start• Expulsion may take place
• Bleeding becomes heavy• Expulsion takes place
• Beginning of a new cycle/fertility
The abortion/Point of no return
Expulsion ≠ Abortion
Medical abortion - clinical aspects, C. Fiala
15
Medical abortion: impact of the interval
Mifepristone Misoprostol
36-48 hours
Reducing the interval needs a higher dose of prostaglandin > more side effects
Medical abortion - clinical aspects, C. Fiala
16
1 2 3 4 5 6 7 8 9 10 11
5
10
15
12 13 14 15 16 17 18 19 20 21
20
22 23 24
in %
(hours after misoprostol)
Time to expulsion of the sac in 1720 women with successfull termination of pregnancy. The women took mifeprostone on day 1 and misoprostol 48 hours later. Uncertain means expulsion at some point during 24 hours following misoprostol. Unknown means expulsion at some point later than 24 after misoprostol.
Source: The New England Journal of Medicine, 1998; 338 (18): 1244
Befor
e m
iso
Mor
e th
an 2
4 h
late
run
know
n
unce
rtain
When does the expulsion take place?
Medical abortion - clinical aspects, C. Fiala
17
D 1: CRL 10 mmhCG 83.439
D 8: E 8 mmhCG 312
The procedure
Medical abortion - clinical aspects, C. Fiala
18
Day 1: hCG 32.000yolk sac visible
Day 8: E 12 mmhCG 837
Day 3: Gestational sac
The procedure
Medical abortion - clinical aspects, C. Fiala
19
Day 7: hCG 7Day 3: Gestational sac
Day 1: Gestational sac5 mmhCG 862
The procedure
Medical abortion - clinical aspects, C. Fiala
20
Day 1: ß-hCG 269 mIU/ml Day 9: ß-hCG 20
The procedure
Medical abortion - clinical aspects, C. Fiala
21
D 28: hCG 100D 10: E 20 mm, hCG 16.841
D 17: OC exD 21: Withdrawl-bleeding
D 1: CRL 6 mmhCG 104.900
D 3: Start OC
The procedure
Medical abortion - clinical aspects, C. Fiala
22
D 1: Gestational + yolk sachCG 13.300
D 3: Start OC
D 19: E 8 mmhCG 718
D 9: missed ABhCG 10.819
D 16: OC exD 18: Withdrawl-bleeding
The procedure
Medical abortion - clinical aspects, C. Fiala
23hCG before and after an abortion
Top curve: women after vacuum aspiration for elective abortionMiddle curve: women with spontaneous abortions uterine aspirationLower curve: women with ectopic removed surgically
,
,
,
,
,
,
,
Montagnana et al., Clinica Chimica Acta, 2011
Medical abortion - clinical aspects, C. Fiala
24
Mean 3,8% (0,1-44); the size of the circles correlates with the number of patients. The smallest circles represent 1 patient; the biggest represent 25 patients, Fiala et al., 2003
0
5
10
15
20
0 2 4 6 8 10 12 14 16 18 20
%
days
Serum hCG at follow-up in % of the initial value
3 cs of successful abortion were at 27,32 and 44%,2 cs of missed abortion at 91 and 159%, 1 cs of continued pregnancy 7.900 %
Medical abortion - clinical aspects, C. Fiala
25
Thickness of the uterine cavity at follow upAverage: 10mm (1-24mm) after successful medical abortion
Endometrium in ultrasound
0
5
10
15
20
25
30
0 2 4 6 8 10 12 14 16 18 20
Days
mm
Fiala et al. Eur J Obstet Gynecol, 2003
New Museum wants old contraceptives
Wanted:
Objects (IUDs,
Cervical caps
etc.), Reports,
posters,
publications
Museum of Contraception and Abortion
www.muvs.org
Vienna
Reproductive Health a Gender Problem
What about
sharing rights
including the
right to
exercise them?
Carrying the burden of
reproduction...
2014